Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, UVA Cancer Center researchers have discovered.

An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

The test, developed by a team at the University of Southampton, uses AI to analyse blood samples for tiny fragments of ...

The breakthrough blood test uses AI to detect the 12 most lethal and common cancers from an mRNA signature which shows if ...

Research suggests the test, known as miONCO-Dx, can detect 12 cancers at an early stage with 99% accuracy. However, a larger ...